Clinical Trial Update: Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) [Phase 2, Phase 3]

View source ↗

Summary

This document reports an ongoing Phase 2/Phase 3 clinical trial evaluating pazopanib for hereditary hemorrhagic telangiectasia-related epistaxis and anemia, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Cure HHT | Conditions: Hereditary Hemorrhagic Telangiectasia, Epistaxis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING